Toshimitsu Yamaoka

Institute of Molecular Oncology, Showa Medical University

Affiliated withShowa Medical University Showa University

Research Area

Biography

Toshimitsu Yamaoka has not added Biography.
If you are Toshimitsu Yamaoka and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 2	Year
Publication title Cited by 4	2017
Publication title Cited by 3	2019

Other Publications

Article	Year
and Amplifications Mediate Resistance to Rociletinib and Osimertinib in Acquired Afatinib-Resistant NSCLC Harboring Exon 19 Deletion/T790M in . Molecular cancer therapeutics\| PubMed ID: 30322949	2019
Phase I study of the combination of gemcitabine and nedaplatin for treatment of previously untreated advanced non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands)\| PubMed ID: 12499100	2003
Regulation of apoptosis during homeostasis and disease in the intestinal epithelium. Inflammatory bowel diseases\| PubMed ID: 16670531	2006
[Two cases of successfully treated invasive pulmonary aspergillosis following influenza virus infection]. Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society\| PubMed ID: 17491315	2007
Effectiveness of intensive follow-up after response in patients with small cell lung cancer. Lung cancer (Amsterdam, Netherlands)\| PubMed ID: 17900754	2008
[Two cases with recurrent non-small cell lung cancer successfully treated with cisplatin and S-1]. Gan to kagaku ryoho. Cancer & chemotherapy\| PubMed ID: 18281776	2008
Patient satisfaction with sedation for flexible bronchoscopy. Respirology (Carlton, Vic.)\| PubMed ID: 18513244	2008
Transactivation of EGF receptor and ErbB2 protects intestinal epithelial cells from TNF-induced apoptosis. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 18701712	2008
Patient willingness to undergo chemotherapy and thoracic radiotherapy for locally advanced non-small cell lung cancer. Psycho-oncology\| PubMed ID: 18942662	2009
Preventive and therapeutic effects of imatinib in Wistar-Kyoto rats with anti-glomerular basement membrane glomerulonephritis. Kidney international\| PubMed ID: 19242505	2009
Phase II study of the combination of nedaplatin and weekly paclitaxel in patients with advanced non-small cell lung cancer. Anticancer research\| PubMed ID: 19443395	2009
Combination effect between bortezomib and tumor necrosis factor alpha on gefitinib-resistant non-small cell lung cancer cell lines. Anticancer research\| PubMed ID: 19528497	2009
Induction chemoradiotherapy followed by surgery for locally advanced non-small cell lung cancer. Oncology reports\| PubMed ID: 19787234	2009
[Chemotherapy-induced myelosuppression and treatment efficacy in extensive-stage small cell lung cancer]. Gan to kagaku ryoho. Cancer & chemotherapy\| PubMed ID: 19920385	2009
IL-17A and IL-17F stimulate chemokines via MAPK pathways (ERK1/2 and p38 but not JNK) in mouse cultured mesangial cells: synergy with TNF-alpha and IL-1beta. American journal of physiology. Renal physiology\| PubMed ID: 20042461	2010
The UGT1A1*28 genotype and the toxicity of low-dose irinotecan in patients with advanced lung cancer. Oncology research\| PubMed ID: 20377135	2010
Are levels of pro-gastrin-releasing peptide or neuron-specific enolase at relapse prognostic factors after relapse in patients with small-cell lung cancer? Lung cancer (Amsterdam, Netherlands)\| PubMed ID: 20537424	2011
Phase II study of S-1, a novel oral fluoropyrimidine, and biweekly administration of docetaxel for previously treated advanced non-small-cell lung cancer. Cancer chemotherapy and pharmacology\| PubMed ID: 20556612	2011
Phase II trial of amrubicin and carboplatin in patients with sensitive or refractory relapsed small-cell lung cancer. Lung cancer (Amsterdam, Netherlands)\| PubMed ID: 21277039	2011
Phase II trial of the combination of carboplatin and irinotecan in elderly patients with small-cell lung cancer. European journal of cancer (Oxford, England : 1990)\| PubMed ID: 21458256	2011
Specific epidermal growth factor receptor autophosphorylation sites promote mouse colon epithelial cell chemotaxis and restitution. American journal of physiology. Gastrointestinal and liver physiology\| PubMed ID: 21617115	2011
[A case of pulmonary aspergilloma concomitant with allergic bronchopulmonary aspergillosis]. Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society\| PubMed ID: 21688647	2011
[The mechanisms of resistance to EGFR-TKIs and challenges to overcome resistance in EGFR mutant non-small cell lung cancer]. Gan to kagaku ryoho. Cancer & chemotherapy\| PubMed ID: 22705678	2012
Myelosuppression induced by concurrent chemoradiotherapy as a prognostic factor for patients with locally advanced non-small cell lung cancer. Oncology letters\| PubMed ID: 22866156	2011
Relationship of circulating tumor cells to the effectiveness of cytotoxic chemotherapy in patients with metastatic non-small-cell lung cancer. Oncology research\| PubMed ID: 23193919	2012
Evaluation of the safety and efficacy of combination chemotherapy with vinorelbine and platinum agents for patients with non-small cell lung cancer with interstitial lung disease. Anticancer research\| PubMed ID: 23225454	2012
Phase II study of concurrent chemoradiotherapy with carboplatin and vinorelbine for locally advanced non-small-cell lung cancer. Molecular and clinical oncology\| PubMed ID: 24772308	2014
Association of pharmacokinetics and pharmacogenomics with safety and efficacy of gefitinib in patients with EGFR mutation positive advanced non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands)\| PubMed ID: 26898617	2016
Acquired Resistance Mechanisms to Combination Met-TKI/EGFR-TKI Exposure in Met-Amplified EGFR-TKI-Resistant Lung Adenocarcinoma Harboring an Activating EGFR Mutation. Molecular cancer therapeutics\| PubMed ID: 27612490	2016
Distinct Afatinib Resistance Mechanisms Identified in Lung Adenocarcinoma Harboring an EGFR Mutation. Molecular cancer research : MCR\| PubMed ID: 28289161	2017
Up-regulation of Syndecan-4 contributes to TGF-β1-induced epithelial to mesenchymal transition in lung adenocarcinoma A549 cells. Biochemistry and biophysics reports\| PubMed ID: 28955801	2016
Molecular-Targeted Therapies for Epidermal Growth Factor Receptor and Its Resistance Mechanisms. International journal of molecular sciences\| PubMed ID: 29140271	2017
Receptor Tyrosine Kinase-Targeted Cancer Therapy. International journal of molecular sciences\| PubMed ID: 30404198	2018